Simultaneous treatment of MM cells with MALAT-1 oligonucleotides and bortezomib significantly upregulates γH2A.X, a marker of double-strand DNA breaks, suggesting the synergistic effect of anti-MALAT1 and bortezomib treatment. Here, MALAT1 is linked to Miyoshi myopathy.